ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY revenue for the last year amounted to 580.60 M HKD, the most of which — 421.89 M HKD — came from its highest performing source at the moment, Neurovascular Interventional Devices, the year earlier bringing 271.41 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY 567.40 M HKD, and the year before that — 379.44 M HKD.